MedPath

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Not Applicable
Completed
Conditions
Central Nervous System Diseases
Carotid Stenosis
Constriction, Pathologic
Cerebrovascular Disorders
Carotid Artery Diseases
Nervous System Diseases
Arterial Occlusive Diseases
Brain Diseases
Pathological Conditions, Anatomical
Vascular Diseases
Interventions
Device: Gore Flow Reversal System
Device: Gore Embolic Filter
Registration Number
NCT01343667
Lead Sponsor
W.L.Gore & Associates
Brief Summary

The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.

Detailed Description

Physicians will have the opportunity to select which embolic protection device, the GORE Flow Reversal System or the GORE Embolic Filter, to use during the carotid artery stenting procedure.

This study is not designed to compare study endpoints between the two treatment arms.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1397
Inclusion Criteria
  • Patient, or patient's legal representative, is able and willing to provide informed consent.
  • Patient must be at least 18 years of age or older.
  • Patient will be selected and treated according to the GORE Flow Reversal System Instructions for Use (IFU) or the GORE Embolic Filter IFU.
Exclusion Criteria
  • Patient is contraindicated for the embolic protection device arm they are selected by the investigator to receive: Either Per the GORE Flow Reversal System IFU if the GORE Flow Reversal System is selected OR Per the GORE Embolic Filter IFU if the GORE Embolic Filter is selected

If the patient is contraindicated for both arms (devices) they may not be enrolled.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GFRS EPDGore Flow Reversal SystemCarotid artery stenting with Gore Flow Reversal System embolic protection device
GEF EPDGore Embolic FilterCarotid artery stenting with Gore Embolic Filter embolic protection device
Primary Outcome Measures
NameTimeMethod
Major Adverse Events (MAE)Onset from start of index procedure to 30-day follow-up assessment

Major Adverse Events include death, stroke and myocardial infarction

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (39)

Appleton Medical Cetner

🇺🇸

Appleton, Wisconsin, United States

Kaiser FOundation Hospitals

🇺🇸

Honolulu, Hawaii, United States

Drexel University

🇺🇸

Philadelphia, Pennsylvania, United States

University of California San Francisco

🇺🇸

San Francisco, California, United States

Hoag Memorial Hospital

🇺🇸

Newport Beach, California, United States

Johns Hopkins Hospital

🇺🇸

Baltimore, Maryland, United States

Indiana University

🇺🇸

Indianapolis, Indiana, United States

Harper Hospital

🇺🇸

Detroit, Michigan, United States

St Joseph Mercy Hospital

🇺🇸

Pontiac, Michigan, United States

Riverside Methodist Hospital

🇺🇸

Columbus, Ohio, United States

W.L. Gore and Associates, Inc

🇺🇸

Flagstaff, Arizona, United States

Cooper University Hospital

🇺🇸

Camden, New Jersey, United States

Southwest General Health Center

🇺🇸

Middleburg Heights, Ohio, United States

Dartmouth Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Ochsner Clinic

🇺🇸

New Orleans, Louisiana, United States

Beth Israel Decaoness Medical Center

🇺🇸

Boston, Massachusetts, United States

St Anthony's Medical Center

🇺🇸

St Louis, Missouri, United States

St Francis Hospital

🇺🇸

Roslyn, New York, United States

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

Wake Heart Research

🇺🇸

Raleigh, North Carolina, United States

Heart Care Research Foundation

🇺🇸

Mokena, Illinois, United States

Mt Sinai Hospital

🇺🇸

New York, New York, United States

Rockford Cardiovascular Associates

🇺🇸

Rockford, Illinois, United States

St John's Medical Center

🇺🇸

Detroit, Michigan, United States

First Coast Cardiovascular Institute

🇺🇸

Jacksonville, Florida, United States

St Joesph's Medical Center

🇺🇸

St Louis, Missouri, United States

Covenant Medical Center

🇺🇸

Saginaw, Michigan, United States

Forsyth Memorial Hospital

🇺🇸

Winston Salem, North Carolina, United States

Spirit Physician Services / Capital Cardiovascular Assoc

🇺🇸

Camp Hill, Pennsylvania, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

York Hospital

🇺🇸

York, Pennsylvania, United States

Mercy Hospital

🇺🇸

Buffalo, New York, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Heritage Valley Health Network

🇺🇸

Beaver, Pennsylvania, United States

Rapid City Regional Hospital

🇺🇸

Rapid City, South Dakota, United States

N. Central Heart Hospital

🇺🇸

Sioux Falls, South Dakota, United States

St Luke's Episcopal

🇺🇸

Houston, Texas, United States

St Lukes Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath